Texas Medical Board Rules for PA Peptide Delegation

Under Texas Medical Board regulations, a physician may delegate the ordering, prescribing, and administration of peptide therapy to a Physician Assistant through a executed Prescriptive Authority Agreement and established clinical protocols. The delegating physician maintains ultimate oversight, requiring ongoing chart audits, protocol maintenance, and strict adherence to state prescriptive delegation rules and compounding guidelines.

Regulatory Framework: TMB Rules for PA Delegation

Integrating peptide protocols into a medical practice requires strict alignment with the Texas Medical Board rules for physician assistant delegation of peptide therapy. In Texas, physician assistants operate under delegated autonomy, meaning their scope of practice is derived directly from the delegating physician’s authority and formal agreement.

Under Chapter 193 and Chapter 185 of the Texas Administrative Code, physicians may delegate prescriptive authority for dangerous drugs and controlled substances to PAs. Because most therapeutic peptides fall under the category of prescription-only legend drugs, delegating their order and administration requires a formal regulatory framework. Practice managers overseeing practices operated by anti-aging doctors or health and wellness doctors must ensure that delegation structures are fully documented prior to initiating patient care.

The Texas Medical Board (TMB) requires that delegating physicians and PAs enter into a formal Prescriptive Authority Agreement (PAA). This legal document defines the specific parameters of delegation, the geographic boundaries of practice, and the precise therapeutic categories the PA is authorized to order and manage.

Key Components of the Prescriptive Authority Agreement (PAA)

To ensure compliance during TMB audits, practice administrators must verify that the PAA includes all legally mandated elements tailored specifically to advanced biological and peptide therapies:

• Identified Delegation Scope: The agreement must explicitly list peptide therapy within the PA’s delegation scope, specifying whether delegation includes legend peptide formulations, compounding preparations, or metabolic regulators.
• Clinical Protocols and Delegation Standing Orders: The practice must maintain clear, written medical protocols outlining approved patient selection criteria, baseline diagnostic testing requirements, contraindications, and emergency intervention plans.
• Quality Assurance and Chart Review Schedule: Texas law requires documented periodic quality assurance meetings. The PAA must define the frequency and methodology for chart reviews, ensuring the physician regularly evaluates delegated clinical decisions.
• TMB Portal Registration: The delegating physician must formally register the PA delegation relationship on their online TMB profile prior to the commencement of delegated prescribing.

Failure to maintain an active, fully compliant PAA can result in administrative disciplinary action against both the supervising physician and the practicing PA. Furthermore, practice managers must archive historical PAAs for several years after termination to maintain an audit-ready compliance trail.

Clinical Execution vs. Operational Governance

Successful delegation of peptide protocols requires a clear distinction between clinical decision-making and operational practice management. Both arms of the practice must coordinate to ensure legal compliance and smooth patient workflow.

The Clinical Responsibilities (Delegating Physician & PA)

From a clinical perspective, the delegating physician retains professional responsibility for the overall standard of care. The PA must execute patient care within the boundaries of established clinical protocols. This includes performing an appropriate initial physical examination, ordering baseline laboratory work (such as endocrine panels or metabolic biomarkers), and confirming that the patient has no clinical contraindications for specific peptide therapies.

The clinician must also verify that any compounded peptide products originate from properly licensed facilities. Given regulatory scrutiny surrounding compounded biologics and peptide preparations, clinicians must ensure that non-FDA-approved bulk substances are not utilized outside of permitted regulatory frameworks.

The Operational Governance (Practice Administrator & Management)

For practice administrators, compliance governance revolves around documentation, supply chain integrity, and risk management. Operational duties include:

• Vendor Compliance Auditing: Verifying that all peptide supplies and clinical formulations are sourced from state-licensed 503A compounding pharmacies or 503B outsourcing facilities that comply with USP standards.
• Meeting Documentation: Tracking and filing monthly or quarterly QA review logs, including signed attendance records and sample chart audit notes.
• Credentialing & Scope Verification: Ensuring the PA’s state license, DEA registration (if applicable for controlled adjuncts), and malpractice coverage explicitly encompass delegative regenerative medicine protocols.
• Workflow Optimization: Standardizing electronic health record (EHR) templates so that PAs can easily attach required delegation protocols and physician co-signatures where appropriate.

Compliance Checklist for Practice Administrators

Practice managers should utilize this structured checklist to audit their practice’s current peptide delegation workflow under TMB standards:

1. Verify Active TMB Delegation Registration: Confirm the delegating physician has designated the PA on the official TMB portal.
2. Execute a Customized PAA: Ensure the PAA contains specific references to peptide therapy, metabolic protocols, and regenerative medicine delegation rather than generic boilerplate language.
3. Establish Written Clinical Protocols: Store standard operating procedures (SOPs) for each peptide protocol in an accessible clinical manual, signed annually by the delegating physician.
4. Schedule and Log Quality Assurance Meetings: Maintain a dedicated binder or digital folder containing meeting dates, topics discussed, and clinical charts reviewed.
5. Audit Compounding Pharmacy Licenses: Collect current Texas State Board of Pharmacy licenses and compliance certificates for all compounding vendors supplying the practice.
6. Review EHR Delegation Templates: Ensure charting templates prompt the PA to record patient history, informed consent, baseline labs, and protocol adherence.

What This Means for Your Practice

Delegating peptide therapy to a qualified PA allows medical practices to expand patient access, optimize clinical capacity, and build scalable wellness service lines. However, non-compliance with Texas delegation statutes poses significant legal and financial risks.

Practice administrators must proactively evaluate their current operational infrastructure. By implementing rigorous PAA documentation, standardizing clinical SOPs, and ensuring complete supply chain compliance, practice leaders protect their license holders while delivering predictable, high-quality care.

To learn more about implementing clinical protocols and procurement frameworks for your operational team, review our regulatory and clinical resources in our blog section or consult our FAQ page for common practice management questions.

Practice Consultation and Support

Navigating regulatory compliance, product sourcing, and workflow integration for regenerative service lines requires dedicated expertise. Contact the team at Dallas Regenerative Solutions through our contact page to discuss practice support, compliant supply solutions, and clinical platform integration.